Intermittent fasting (IF) that limits eating times was found to reduce chronic pain and improve cognition that had declined due to pain in animal experiments.
The researchers identified a new pathway in which alterations of the gut microbiota affect brain inflammatory responses.
The study was conducted jointly by the First Affiliated Hospital of Zhengzhou University in China and Chiba University in Japan. Rats with experimentally induced chronic pain were subjected to IF consisting of 24 hours without food followed by 24 hours of free feeding, repeated for 38 days.
After the 38‑day regimen, the investigators observed reductions in pain behaviors and improvements in cognitive performance, suggesting that IF may modulate pain‑related brain inflammation via gut microbiota changes.
Investigación e Informes6 sept 2026•1 min de lectura
Intermittent Fasting Reduces Chronic Pain and Improves Cognition in Rat Study
Animal experiments show time‑restricted feeding lowers chronic pain and restores pain‑related cognitive deficits, linked to gut microbiota‑driven brain inflammation.
Recopilado por el equipo de PharmaCountry · Fuente: KPA News
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración